Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Celerion announced the launch of on-site services for rapid sterility testing (validated alternative method to USP <71>) and dose formulation analysis.
read more
CordenPharma has announced its largest strategic investment to date with a committed spend of ~€900m over the next 3 years to grow its Peptide technology platform.
read more
Eurofins CDMO Alphora Inc. announced the expansion of its API capacity and capabilities with the completion of its new API manufacturing facility at its site in Mississauga, Canada.
read more
Eurofins CDMO Alphora Inc. announced the expansion of its API capacity and capabilities with the completion of its new API manufacturing facility at its site in Mississauga, Canada.
read more
Nusano Inc., a physics company producing medical radioisotopes, and PharmaLogic Holdings Corp., a radiopharmaceutical contract development and manufacturing organization ("CDMO"), announced a supply agreement to provide a more efficient and reliable ...
read more
Palisade Bio, Inc. announced the successful completion of the first Good Manufacturing Practice (GMP) batch of its drug substance PALI-2108, an orally administered, locally acting colon-specific phosphodiesterase-4 (PDE4) inhibitor prodrug in ...
read more
Rentschler Biopharma SE announced that the company’s new state-of-the-art production line, formerly known as the Rentschler Biopharma Manufacturing Center (RBMC), in Milford, MA in the U.S. is now fully operational.
read more
Selkirk Pharma, Inc. announced the appointment of Colleen Dixon as the company’s new Chief Executive Officer. Dixon, who formerly served as Vice President of Program Management at Selkirk Pharma, succeeds Patrick Haffey, the founder of Selkirk Pharma...
read more
Charles River Laboratories International, Inc. announced a contract development and manufacturing organization (CDMO) agreement to produce Good Manufacturing Practice- (GMP) plasmid DNA.
read more
Cambrex announced the expansion of its stability storage business, Q1 Scientific, which offers environmentally-controlled stability storage services to the pharmaceutical, medical device, and life sciences industries.
read more
Harvest Integrated Research Organization (HiRO), announced its acquisition of DeltaMed Solutions, an emerging CRO with a robust foothold in the US. The acquisition, advised by Evercore as financial advisor, marks HiRO's third CRO acquisition since ...
read more
The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, announced the expansion of its central laboratory operations in Kentucky dedicated to accelerating pharmaceutical and biotech customers’ ...
read more
Navin Molecular, an Indian-headquartered CDMO with small molecule development and manufacturing capabilities, announced a Rs 288 Crore (approximately US$35 million) investment to construct a 9,000-square-metre GMP manufacturing plant in Dewas, India.
read more
Abzena, the leading end-to-end integrated contract and development manufacturing organization (CDMO) for complex biologics and bioconjugates, and Argonaut Manufacturing Services, Inc., a cGMP CDMO serving the biopharmaceutical and diagnostics ...
read more
Hovione has announced the opening of a state-of-the-art continuous tableting (CT) line at its R&D Center in Lisbon.
read more